Back to Screener

Healthcare

Opus Genetics, Inc.(IRD)

Live Price

Offline

$3.72

+0.27% today

1Y Change

+315.31%

Window

Jun 27, 2025 โ†’ Jun 18, 2026

Market Cap
$360.00M
Revenue Growth
+29.1%
EPS Growth
+62.8%
Dividend Yield
0.0%

Coverage: 245 bars ยท Jun 27, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Opus Genetics, Inc. (IRD) is a Healthcare stock with a market cap of $360.00M and listed on NASDAQ. The stock last traded around $3.72 and up 315.3% across the available one-year price window (Jun 27, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +29.1%, EPS growth of +62.8%, a dividend yield of 0.0%. What stands out right now is revenue +29.1%, EPS +62.8%, free cash flow -37.8% with operating margin -271.9% and ROIC -90.9%. Valuation already assumes a fairly strong business story at price/sales 25.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines IRD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

IRD vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

IRD

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

IRD Max Drawdown

-32.35%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for IRD and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 21, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 21, 26
โ€”
Est -0.16
โ€”
โ€”
Est 3144.0B
โ€”
May 21
โ€”
Mar 10, 26
โœ—
-0.14
Est -0.11
-27.3%
โ€”
Est 3163.7B
โ€”
Mar 10
โ€”
Nov 12, 25
โœ“
-0.12
Est -0.14
+14.3%
3079.0B
Est 3071.4B
+0.3%
Nov 12
โ€”
Aug 13, 25
โœ“
-0.12
Est -0.25
+52.0%
2882.0B
Est 3083.3B
-6.5%
Aug 13
โ€”
May 15, 25
โœ“
-0.32
Est -0.34
+5.9%
4370.0B
Est 3400.0B
+28.5%
May 15
โ€”
Mar 31, 25
โœ—
-1.27
Est -0.34
-273.5%
4302.0B
Est 3388.5B
+27.0%
Mar 31
โ€”
Nov 12, 24
โœ“
-0.29
Est -0.30
+3.3%
3867.0B
Est 11104.3B
-65.2%
Nov 12
โ€”
Aug 13, 24
โœ—
-0.30
Est -0.25
-20.0%
1112.0B
Est 2453.3B
-54.7%
Aug 13
โ€”
May 10, 24
โœ—
-0.29
Est -0.18
-61.1%
1711.0B
Est 5339.7B
-68.0%
May 10
โ€”
Mar 9, 24
โœ—
-0.22
Est -0.05
-315.2%
1691.0B
Est 5356.5B
-68.4%
Mar 9
โ€”
Nov 13, 23
โœ“
0.25
Est -0.22
+211.8%
11935.0B
Est 3025.2B
+294.5%
Nov 13
โ€”
Jun 30, 23
โœ—
-0.24
Est -0.23
-4.7%
3674.0B
Est 2425.1B
+51.5%
Jun 30
โ€”
Mar 31, 23
โœ—
-0.28
Est -0.15
-79.6%
1749.0B
Est 2951.4B
-40.7%
Mar 31
โ€”
Dec 31, 22
1.58
Est โ€”
โ€”
39850.0B
Est โ€”
โ€”
Dec 31
โ€”
Sep 30, 22
โœ“
-0.22
Est -0.28
+21.6%
โ€”
Est โ€”
โ€”
Sep 30
โ€”
Jun 30, 22
-0.25
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Jun 30
โ€”
Mar 31, 22
-0.35
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Mar 31
โ€”
Dec 31, 21
-0.35
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Dec 31
โ€”
Sep 30, 21
-0.25
Est โ€”
โ€”
489.0B
Est โ€”
โ€”
Sep 30
โ€”
Jun 30, 21
-0.52
Est โ€”
โ€”
100.0B
Est โ€”
โ€”
Jun 30
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar